NasdaqCM - Nasdaq Real Time Price USD

Viking Therapeutics, Inc. (VKTX)

67.75 +0.75 (+1.13%)
As of 11:09 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
114,363.00
100,827.00
70,355.00
55,682.00
42,662.00
Operating Income
-114,363.00
-100,827.00
-70,355.00
-55,682.00
-42,662.00
Net Non Operating Interest Income Expense
20,643.00
14,932.00
1,530.00
685.00
3,127.00
Other Income Expense
--
--
-42.00
7.00
40.00
Pretax Income
-93,720.00
-85,895.00
-68,867.00
-54,990.00
-39,495.00
Net Income Common Stockholders
-93,720.00
-85,895.00
-68,867.00
-54,990.00
-39,495.00
Diluted NI Available to Com Stockholders
-93,720.00
-85,895.00
-68,867.00
-54,990.00
-39,495.00
Basic EPS
-0.92
-0.91
-0.90
-0.71
-0.54
Diluted EPS
-0.92
-0.91
-0.90
-0.71
-0.54
Basic Average Shares
100,623.36
94,346.99
76,833.63
77,198.00
72,597.00
Diluted Average Shares
100,623.36
94,346.99
76,833.63
77,198.00
72,597.00
Total Operating Income as Reported
-114,363.00
-100,827.00
-70,355.00
-55,682.00
-42,662.00
Total Expenses
114,363.00
100,827.00
70,355.00
55,682.00
42,662.00
Net Income from Continuing & Discontinued Operation
-93,720.00
-85,895.00
-68,867.00
-54,990.00
-39,495.00
Normalized Income
-93,720.00
-85,895.00
-68,825.00
-54,997.00
-39,535.00
Interest Income
20,731.00
15,020.00
1,589.00
703.00
3,233.00
Net Interest Income
20,643.00
14,932.00
1,530.00
685.00
3,127.00
EBIT
-114,363.00
-100,827.00
-70,355.00
-55,682.00
-42,662.00
EBITDA
-114,069.00
-100,535.00
-70,064.00
-55,386.00
-42,385.00
Reconciled Depreciation
294.00
292.00
291.00
296.00
277.00
Net Income from Continuing Operation Net Minority Interest
-93,720.00
-85,895.00
-68,867.00
-54,990.00
-39,495.00
Total Unusual Items Excluding Goodwill
--
--
-42.00
7.00
40.00
Total Unusual Items
--
--
-42.00
7.00
40.00
Normalized EBITDA
-114,069.00
-100,535.00
-70,022.00
-55,393.00
-42,425.00
12/31/2020 - 4/28/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NVO Novo Nordisk A/S
132.68
+0.60%
 
ALT Altimmune, Inc.
7.98
-0.37%
 
RXRX Recursion Pharmaceuticals, Inc.
9.48
+0.64%
 
IOVA Iovance Biotherapeutics, Inc.
10.24
-0.05%
 
CRSP CRISPR Therapeutics AG
55.56
-1.17%
 
MDGL Madrigal Pharmaceuticals, Inc.
225.81
+2.61%
 
NVAX Novavax, Inc.
14.17
+8.95%
 
AXSM Axsome Therapeutics, Inc.
77.78
+1.62%
 
VRTX Vertex Pharmaceuticals Incorporated
447.01
+0.40%
 
CYTK Cytokinetics, Incorporated
59.85
+0.54%